AzTrials
AzTrials

Substance AbuseCASPARNCT01813864

Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)

A study testing CASPAR/Treatment Planning in people with Substance Abuse, run by Treatment Research Institute at 7 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Substance Abuse
What is being tested?
CASPAR/Treatment Planning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
352 participants
Where
7 sitesUnited States
Study dates
Aug 2004to Jul 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • currently attending substance abuse treatment

Who cannot join

  • incarceration
  • under 18

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

United States7 sites
  • Aldie Counseling

    Bensalem, Pennsylvania, 19020

  • SODAT

    Camden, New Jersey, 08103

  • Cape Counseling

    Cape May Court House, New Jersey, 08210

  • Genesis Counseling

    Collingswood, New Jersey, 08108

  • Aldie Counseling

    Doylestown, Pennsylvania, 19118

  • Malvern Institute

    King of Prussia, Pennsylvania, 19406

  • SODAT

    Woodbury, New Jersey, 08096

Other trials in United States

About this study

The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client outcomes. This is a two phase study in which we compare clients pre-intervention to clients post-intervention.

Clients from Phase II (Post-Intervention) compared to Phase I (Pre-Intervention) will:have treatment plans that better match the problems reported at assessment; receive services that better match their needs, as reported during the assessment/intake; show better results during treatment performance on the Treatment Services Review (TSR), including attending a greater percentage of their scheduled treatment sessions and increased satisfaction with the Treatment Planning process; show better client outcomes at 3 month follow-up on primary drug and alcohol measures, including Breathalyzer and urine drug screen, and secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.

Read the detailed description

This protocol will specifically target identified organizational barriers by implementing the CASPAR system as a site-wide Quality Improvement Initiative (QI Initiative) study and enrolling seven sites in Bucks and Montgomery Counties in Pennsylvania and in the Southern New Jersey region who (1) were the most active sites in participating in the focus groups and provided feedback that led to the development of the new Quality Improvement protocol, (2) want to focus organizational effort and attention on improving treatment planning and problem-services matching, (3) met additional inclusion criteria (detailed below). They are all located within Bucks and Montgomery Counties in Pennsylvania and within a 70 mile radius of Atlantic City, New Jersey.

Executive directors at all invited programs will sign a Letter of Agreement (LoA) with Treatment Research Institute (TRI) that as an organization they will support their counselors in attending training, providing individualized treatment plans as well as monthly individualized sessions dedicated to problem-service matching; will add items necessary to their assessment to make sure it is equally comprehensive as the Addiction Severity Index (ASI), and will allow TRI to recruit clients for follow-up to evaluate the effectiveness of the QI Initiative implementation. The LoA will detail all site-specific expectations, along with benefits to the program, including free counselor and supervisor training (along with Certified Addictions Counselor (CAC) and Certified Alcohol Drug Counselor (CADC) credits), free software, and monetary compensation, $2,000 for site participation in Phase I of the study and $3,000 for site participation in Phase II of the study. Directors will also be provided with a detailed Director Information Sheet outlining aspects of the Quality Improvement Initiative outlined in the LoA.

TRI staff will provide counselors and supervisors with the treatment planning training as well as the CASPAR Resource Guide software and training on its use. These activities will be initiated as an organization-wide Quality Improvement Initiative, and as such, will be implemented with all counselors at each program. No data will be collected from the counselors, nor will we discuss or report on client outcomes grouped by counselor.

This will be a 2-Phase project. TRI staff will recruit up to 6 eligible clients per counselor prior to providing the CASPAR training and up to 6 additional clients after providing training. Based on current data from the sites, we expect a minimum of 36 counselors to be involved in the Quality Improvement Initiative.

Update June 1st 2009 - Based on current recruitment levels achieved and analysis needs, we are projecting recruitment of approximately 320 subjects.

We will continue to evaluate the effectiveness of this enhanced protocol by addressing the same aims and using primarily the same client instruments previously approved by this Institutional Review Board (IRB, some have been modified, see full discussion below). We will compare client outcomes before (Phase I) and after the individualized treatment planning and problem-service matching components are introduced (Phase II). As before, we expect to see pre-post differences in problem-treatment plan matching, treatment plan-service matching, and in the number and appropriateness of services clients receive; we also expect to see pre-post differences in client outcome such as treatment attendance, treatment retention, breathalyzer, and urinalysis results, the same measures and outcomes in the original design.

Conditions
Substance Abuse
Being tested
CASPAR/Treatment Planning
Keywords
treatment planning, resource guide, service matching, Service matching for substance abuse clients, CASPAR resource guide, Improved treatment planning
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CASPAR/Treatment PlanningBehavioural

    Also called CASPAR, Technology Tranfer, Assessment

    All counselors in the study will receive additional training in treatment planning and the CASPAR Resource Guide software to easily identify and link patients to services not available at substance abuse treatment centers such as General Educational Development (GED) training, dental clinics, job training, etc.

Study groups in NCT01813864
Study groupRoleWhat they receive
CASPAR Resource GuideExperimentalTreatment Enhanced/CASPAR-- All counselors in this study will receive a training and take part in the experimental arm of the study in Phase 2.
Receives: Behavioral: CASPAR/Treatment Planning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Better client outcomes at 3 month follow-up on primary drug and alcohol measures

    Measured: 3 months post treatment start.

Secondary outcomes (3)
  1. Better client outcomes at 3 month follow-up on secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.

    Measured: 3-months post treatment start.

  2. Increased satisfaction with the Treatment Planning process.

    Measured: Assessed at 2, 4, 8 and 12 weeks.

  3. Improved match between patient problems and treatment plan & services received.

    Improved match between:

    1. Patient problems identified at admission and treatment plan.
    2. Patient problems identified at admission and services received.

    Measured: Up to 3-months post treatment start.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2013 (estimated)
  2. Study startAug 2004
  3. Primary completionMar 2010
  4. Study completionJul 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
352 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01813864
Sponsor's protocol ID
R01DA015125
Other IDs
5R01DA015125-05
Acronym
CASPAR
Status last verified
Mar 2023
First submitted
24 Jun 2010
Last updated
28 Mar 2023
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing CASPAR/Treatment Planning in people with Substance Abuse, run by Treatment Research Institute at 7 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Better client outcomes at 3 month follow-up on primary drug and alcohol measures (time frame: 3 months post treatment start.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in